Metrics
- Price
- $118.63
- Market Cap $M
- 9,758
- Rel Volume
- 1.15
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- +69.30%
- 1D
- -0.35%
- 1W
- -1.33%
- 1M
- +12.47%
- 1M Slope
- +15.01%
- 6M Range
- 78.58%
- Score
- 81.4
- Sharp
- 4.9
Volume
Profile
Kymera Therapeutics is a biotechnology company developing targeted protein degradation therapies for inflammatory diseases and cancer using novel small-molecule medicines.
Biotech
Pharmaceuticals